What is ‘Nimbus'? New COVID variant spreading in THESE 14 US states, know symptoms here
Health officials first found the variant in the US in late March through testing international travelers at airports. Since then, it's been spotted in over a dozen states, and numbers are expected to grow.
On May 23, the World Health Organization called NB.1.8.1 a 'variant under monitoring' because of how fast it's spreading and changes in its spike protein that could affect how easily it spreads. The nickname 'Nimbus' was given in late May on X by Canadian evolutionary biologist T. Ryan Gregory, who also came up with names for other COVID variants like the 'FLiRT' strains.
While this variant is making up more cases in the US, overall COVID numbers haven't changed much. As of June 7, the test positivity rate was 3%, which is just a 0.2% increase from the previous week. Hospital stays for COVID are actually going down, according to the CDC. Their wastewater tracking, as of June 6, also shows a low level of virus activity across the country.
Still, experts believe this could shift in the next few months. Every summer since 2020 has brought a jump in COVID cases in the US, and the arrival of this new variant has many keeping an eye out for another rise.
Also Read: COVID horror: Over 300 people in US still dying from coronavirus every week, Here's why
Between May 25 and June 7, NB.1.8.1 was responsible for about 37% of COVID cases in the US, up from 15% in the previous two weeks. The top variant at the moment, LP.8.1, is causing 38% of infections.
However, the CDC said its ability to track exact numbers is 'low' because not enough virus samples are being sequenced. The agency hasn't shared regional data yet, but according to sequences posted on the GISAID database, the Nimbus variant has been found in at least 14 states:
• Arizona
• California
• Colorado
• New Jersey
• New York
• Hawaii
• Illinois
• Maryland
• Massachusetts
• Ohio
• Rhode Island
• Vermont
• Virginia
• Washington
Worldwide, the WHO said that as of May 18, NB.1.8.1 had been detected in at least 22 countries and made up about 10.7% of COVID cases.
Experts believe the number of cases caused by this variant will likely continue to rise in the US, based on what's happening in other parts of the world.
The virus behind COVID (SARS-CoV-2) keeps changing. These mutations sometimes help it spread faster or dodge immune protection from past infection or vaccines.
Like other omicron descendants, NB.1.8.1 spreads quickly. It came from a mix of previous variants and has multiple spike protein mutations, which might help it latch onto human cells more effectively. A May study, though not peer-reviewed yet, said these changes could help it spread faster and possibly outcompete other variants in the future.
Based on its makeup and how quickly it's spreading, it's likely that Nimbus is more transmissible than older versions of the virus—but experts say it's too soon to say exactly how it compares.
So far, there's no sign that it causes worse symptoms than other variants. According to the WHO, the overall risk from this variant is still considered 'low.'
It's not yet clear if NB.1.8.1 will become the dominant variant or cause a large summer spike, but experts say it's possible.
'It's hard to predict whether this variant or another will take off and cause a wave … but its likely that it won't be as severe as what we experienced before 2023,' Dr. Albert Ko, professor of public health, epidemiology and medicine at Yale School of Public Health, as cited by Today report.
In the US, most people now have some level of immunity—either from a past infection or vaccination. It's estimated that about 90% of Americans have already been exposed to the virus. But immunity fades over time.
'The longer we get from the last surge or the last vaccination campaign, the more people are susceptible,' Andy Pekosz, Ph.D., professor at Johns Hopkins Bloomberg School of Public Health, previously said.
Add summer travel, big events, and a new variant like Nimbus, and conditions are right for more infections. According to the CDC, COVID tends to peak twice each year in the US—once in winter, and again during summer (June to August). But how big each wave is can vary.
Based on past years, experts expect some increase this summer. 'We may see an upswing (this) summer as in previous years, and this is expected to be smaller compared to what we experience in the winter,' says Ko.
Right now, symptoms from this variant appear similar to other recent omicron strains. These include:
• Sore throat
• Cough
• Runny or stuffy nose
• Trouble breathing
• Fever or chills
• Headache
• Body aches
• Fatigue
• Loss of smell or taste
Anyone can get sick from COVID, but older adults (especially those over 65), people with weakened immune systems, and those with underlying health issues are more likely to get very sick, according to the CDC.
COVID vaccines still help prevent severe illness, hospitalization, and death. With all the changes to vaccine guidance, you might be wondering if you need another dose.
The CDC says the current 2024–2025 COVID vaccines are still available and are recommended for most adults 18 and up.
'Those in high-risk groups should consider getting the vaccine now if they haven't been vaccinated in the last six months and consider receiving an updated vaccine for the upcoming winter season,' says Ko.
WHO also said the current COVID vaccines should still work against NB.1.8.1.
The next round of vaccines for 2025–2026 will be geared toward the LP.8.1 variant and are expected in the fall. But US Health and Human Services Secretary Robert F. Kennedy Jr. recently announced changes that might limit who can get these shots.
Under the new guidelines, the upcoming vaccine will be offered only to adults 65 and older, and to those aged 12–64 with at least one medical condition. Routine COVID vaccines are no longer recommended for healthy children or pregnant women by the CDC, though many doctors disagree.
If you're unsure whether you should get the COVID shot, talk to your healthcare provider.
To stay safe, health officials recommend testing when you feel sick, staying home when you're ill, masking in crowded indoor places, and social distancing. The government no longer mails out free test kits, but some free or low-cost tests are still available.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
3 hours ago
- Time of India
NZP to set up India's first biosafety level-3 lab for animal disease detection
Hyderabad: The Nehru Zoological Park (NZP) intends to set up a biosafety level-3 (BSL-3) lab on its premises soon, officials from the zoo said. A BSL-3 lab is a disease-detecting facility used to identify zoonotic diseases in animals and prevent their spread to human beings and vice versa. Once operational, it will help the zoo conduct everyday testing of the animals, help control the spread of viral infections, and also prepare for long-term disease management. "We have seen what COVID-19, a zoonotic disease that was transmitted from bats, could do to the human population. With the lab in place, we can constantly monitor the health of the animals and any potential viruses they may be carrying. Moreover, in a zoo like ours, where animal-human interaction is high, it becomes even more important to set up this lab to safeguard our visitors," said Sunil S Hiremath, the director of NZP. Presently, the zoo has a veterinary hospital that it uses to treat its animals for medical conditions and an in-house lab, where the zoo uses faecal and blood sample analysis for primary disease diagnosis like salmonellosis, gastrointestinal issues like acute or chronic gastroenteritis, and conditions like tuberculosis. It relies on institutes like the veterinary biological research institute (VBRI) and the PV Narasimha Rao Telangana veterinary university for lab diagnosis of secondary diseases like parasitical, bacterial, and viral infections, according to biologists and veterinary doctors working in the zoo. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Could This NEW Collagen Blend Finally Reduce Your Cellulite? Vitauthority Learn More Undo You Can Also Check: Hyderabad AQI | Weather in Hyderabad | Bank Holidays in Hyderabad | Public Holidays in Hyderabad | Gold Rates Today in Hyderabad | Silver Rates Today in Hyderabad "It takes two or three days to get results from these institutes, but once we set up the lab in the zoo, we will be able to get instant results, in a matter of a few hours," said MA Hakeem, a veterinary doctor working with NZP. Currently, the zoo is in the process of drafting a proposal to the central govt to get the necessary approvals. Once the project is approved, it will be launched as a govt of India project, officials said. "My team and I are in the process of finalising the details for the lab. Once that is done, we should have a clearer picture of how much the lab is going to cost us and how much space it will take," the director said. "We have the necessary manpower to run it successfully too. We have so many qualified scientists in the zoo, and the city is home to a number of reputed veterinary institutes and colleges like the VBRI and the Veterinary University in Rajendranagar, with whom we'll collaborate," the director added. If the project goes through, NZP will become the first zoo in the country to have a BSL-3 lab. Stay updated with the latest local news from your city on Times of India (TOI). Check upcoming bank holidays , public holidays , and current gold rates and silver prices in your area.
Hindustan Times
9 hours ago
- Hindustan Times
Focus on rabies control, not stray dog population
The current debate about whether stray dogs in Delhi should have a home on the street or be rounded up into pounds has generated strong feelings on all sides. Regardless of which way a three-judge bench of the Supreme Court rules, the fundamental challenge remains curbing of rabies, the disease reported to be responsible for the death of the six-year-old which sparked this debate. Removing the roughly million stray dogs from Delhi's streets will only reduce rabies cases and deaths by less than 2% nationwide. A more productive public health approach would be to focus on rabies rather than stray dogs. India has had enormous success in infectious disease control through vaccinations, examples being smallpox, polio, maternal tetanus and most recently, Covid-19. The country can then surely make significant progress towards the World Health Organization (WHO)'s goal of zero rabies deaths by 2030 without eliminating the 60 million stray dogs in India. But we are far from that goal. India accounts for one in three rabies deaths globally and over two-thirds in Asia. According to WHO data, there are an estimated 18,000-20,000 deaths from rabies each year in India. In comparison, China, which has 40 million stray dogs, reported an average of only 433 rabies cases per year between 2015 and 2021. The number of rabies deaths has declined from 3,300 in 2007 to fewer than 300 deaths in 2020. How did China manage to control rabies without killing its stray dogs? It adopted a one-health approach to rabies control, ensuring close coordination between the human and animal health departments, widening access to post-exposure vaccines (rabies is the only infectious disease that can be addressed using a vaccine post-exposure to the virus), expanding vaccination of all stray dogs and improving surveillance of all dog bites and rabies. China administers approximately 12-15 million rabies vaccine doses every year, at a cost of about $1 billion. India's rabies control programme is poorly funded and, unlike other disease control programmes, straddles two ministries — health and animal husbandry. With poor coordination, the programme has been a failure as evidenced by the rising numbers of rabies cases. A few municipalities like Mumbai and Goa have successfully reduced rabies cases and deaths, but nationally, rabies control has been a failure. The issue pits the right of humans to live safely without getting bitten or attacked against that of most dogs who do not bite anyone. The deaths of children and the elderly due to dog attacks is painful and unacceptable. It is also unacceptable that we consign millions of dogs to a painful death in dog pounds and shelters. For many human communities, strays are part of the community without a designated pet owner. They provide security against outsiders, protection from wild animals, and are generally fed by multiple households. In many instances, most stray dogs exist because of the support of people across the country, and not just because of a small group of urban, well-heeled animal lovers. It will be impossible to get community participation to control rabies if people view the government's programme as an effort to kill their dogs. Taking this approach in a country with deeply ingrained respect for all life, we may achieve control of neither stray dog population nor of rabies. The seeds of the current situation were sown by the poorly conceived Animal Birth Control (ABC) Rules, 2001 (updated in 2023) which prevents rabid dogs from being euthanised. Rabid dogs can only be isolated until they die, often a painful death. Even dogs that bite people can be removed from an area after a lengthy investigation and bureaucratic process, which all but ensures that the dog remains in the area. These laws have likely caused an increase in bites and rabies and have diminished public support for stray dogs. In the name of love for animals, the leadership that pushed through that act without much debate has created an untenable situation that forces us to choose between human and animal life. A public health solution that puts the focus on rabies and dogs that attack humans is far more likely to succeed. In the short term, we must replace the misguided ABC rules with a more common-sense set of guidelines that allow removal of biting and rabid dogs from communities. In the longer term, India should aim to remove all dogs from streets with the aim of eliminating all rabies deaths and ensuring that both humans and dogs are protected. Ramanan Laxminarayan is president of the One Health Trust. The views expressed are personal.
New Indian Express
13 hours ago
- New Indian Express
Madhira mimicry artist Lanka Kondaiah honoured for blending folk art with public health awareness
KHAMMAM: Celebrating art with a purpose, a veteran mimicry artist from Madhira wins recognition for blending tradition with public health awareness. Lanka Kondaiah, a renowned folk mimicry artist (also known as Madhira Asha Mitra) and social worker, receives a Best Service Appreciation Certificate on Friday from District Collector Anudeep Durishetty, in the presence of Additional Collector Sreeja and Khammam Municipal Commissioner Abhishek Agasya. The event is administered by Dr Banoth Kalavathibhai. The award acknowledges Kondaiah's unique way of engaging with the community — using folk and mythological art forms to raise awareness in rural and urban areas about long-term and debilitating diseases. He educates the public on TB, AIDS, leprosy, polio, COVID-19, dengue, and malaria through his creative style. The honour comes under the 'Best Services' category, highlighting his contribution to central and state health initiatives. Speaking at the event, Kondaiah expresses gratitude to the District Medical and Health Department, various programme officers, and the PHC Denukur doctors for recognising his service. He says the award brings congratulations from many quarters: distinguished residents and political leaders of Madhira, members of the Arya Vysya community, farmer groups, employee and teacher unions, media friends, health staff, fellow artists, and well-wishers.
